Effect of cyclooxygenase-2 inhibition on renal function after renal ablation

Hypertension

Volumn 34, Issue 4 II, 1999, Pages 848-853

  Sanchez, Pedro Lopez ^a,b   Salgado, Luis Miguel ^a   Ferreri, Nicholas R ^c   Escalante, Bruno ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cyclooxygenase; Kidney failure; Prostaglandins; Renal ablation; Renal physiology

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTENSION; KIDNEY FAILURE; MALE; NONHUMAN; OSMOLARITY; PATHOPHYSIOLOGY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN URINE LEVEL; RAT; SODIUM URINE LEVEL; URINE VOLUME; VASODILATATION;

EID: 0032711450     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.34.4.848     Document Type: Article

References (33)

1. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85-F93.
2. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging: renal ablation and intrinsic renal disease. N Engl J Med. 1982;307:652-657.
3. Dunn MJ. Renal prostaglandins. In: Dunn MJ, ed. Renal Endocrinology. Baltimore, Md: Williams & Wilkins: 1983:1-74.
4. Torres VE, Romero JC, Stong CG, Wilson DM, Walker VR. Renal prostaglandin E during acute renal failure. Proslaglandins. 1974;8: 353-360.
5. Kirschenbaum MA, Serros ER. Effect of prostaglandin inhibition on glomerular filtration rate in normal and uremic rabbits. Prostaglandins. 1981;22:245-254.
6. Torres VE, Stong CG, Romero JC, Wilson DM. Indomethacin enhancement of glycerol induced acute renal failure in rabbits. Kidney Int. 1975;7:170-178.
7. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam and sulindac in patients with asymptomatic renal failure: a prospective randomized, crossover comparison. Ann Intern Med. 1990;112:568-576.
8. O'Banion MK, Winon VD. Young DA. DNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A. 1992;89:4888-4892.
9. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Ann N Y Acad Sci. 1994;744:50-57.
10. O'Neill PO, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330: 156-160.
11. Evett GE, Xie W, Chipman JG, Robertson DL, Simmons DL. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens and oncogens. Arch Biochem Biophys. 1993; 306:169-177.
12. Futaki W, Takahashi S, Yukoyama M, Arai L, Higuchi S, Otomo S. NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 1994;47:55-59.
13. DeWitt DL. Meade EA, Smith WL. PGH synthase isozyme selectivity: the potential safer nonsteroidal antiinflammatory drugs. Am J Med. 1993; 95:40S-44S.
14. Wang JL, Cheng HF, Zhang MZ, McKanna JA, Harris RC. Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am J Physiol. 1998;275:F613-F622.
15. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, Trzaskos JM. Renal abnormalities and altered inflammatory response in mice lacking cyclooxygenase II. Nature. 1995;378:406-409.
16. Yoshida Y, Fogo A. Ichikawa I. Glomerular hemodynamic changes vs hypertrophy in experimental glomerular sclerosis. Kidney Int. 1989;35: 654-660.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem. 1976;72:248-254.
18. Chen G, Kamal M, Hannon R, Warner TD. Regulation of cyclo-oxygenase gene expression in rat smooth muscle cells by catalase. Biochem Pharmacol. 1998;55:1621-1631.
19. Futaki N, Arai I, Hamasaka Y, Takahashi S, Higuchi S, Otomo S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol. 1993;45:753-755.
20. Masferrer J, Zweifel B, Manning P, Hauser S, Leahy K, Smith W, Isakson P, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994; 91:3228-3232.
21. Pelayo JC, Shanley PF. Glomerular and tubular adaptive responses to acute nephron loss in the rat: effect of prostaglandin synthesis inhibition. J Clin Invest. 1990;85:1761-1769.
22. Nath KA, Chmielewski DH, Hostteter TH. Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons. Am J Physiol. 1987; 252:F829-F837.
23. Bidani AK, Schwartz MM, Lewis EJ. Renal autoregulation and vulnerability to hypertensive injury in remnant kidneys. Am J Physiol. 1987; 252:F1003-F1010.
24. Pelayo JC, Quan AH, Shanley PF. Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol. 1990; 258:F414-F422.
25. Yanagisawa H, Morrissey J, Klahr S. Mechanism of enhanced eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction. Am J Physiol. 1991;261:F248-F255.
26. Seibert K, Masferrer JL, Needleman P, Salvemini D. Pharmacological manipulation of cyclooxygenase-2 in the inflamed hydronephrotic kidney. Br J Pharmacol. 1996;117:1015-1020.
27. Harris RC, McKanna JA, Akai Y, Jacobson HR, DuBois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94: 2504-2510.
28. Vio CP, Cespedes C, Gallardo P, Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension. 1997;30:687-692.
29. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclooxygenase-2 in rat nephron development. Am J Physiol. 1997;273:F994-F1002.
30. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implications for renal function. Am J Physiol. 1997;272:F460-F468.
31. Ichihara AL, Imig JD, Inscho EW, Navar G. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neural NOS. Am J Physiol. 1998;275:F605-F612.
32. Taub M, Sato G. Growth of functional primary cultures of kidney epithelial cells in defined medium. J Cell Physiol. 1980;105:369-378.
33. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension. 1997;29:297-302.